Geometry matched FePt Melaninn Nanoparticles for Breast Cancer

Abstract Precision oncology demands therapeutic systems capable of targeting cancer cells with nanoscale accuracy while minimizing off‑target damage. This work proposes an integrated conceptual framework for a geometry‑matched FePt–melanin nanoparticle designed specifically for HER2‑positive breast cancer. The system combines an L1₀ FePt nanodisc core—selected for its controllable magnetic anisotropy—with a conformal melanin shell that provides photothermal conversion, biocompatibility, and a functional surface for HER2‑specific ligand attachment. By matching nanoparticle geometry to the nanoscale architecture of HER2 receptor clusters, the design enables selective membrane‑level binding and controlled orientation under external magnetic fields. A stepwise engineering approach is presented, detailing core geometry selection, shell construction, ligand functionalization, activation physics, and a multilayer failsafe architecture. These components culminate in a light‑based treatment walk‑through using focused near‑infrared (NIR) illumination. In this protocol, nanoparticles accumulate at HER2‑dense membrane regions, are verified through imaging, and are activated only within a spatially confined NIR field, producing hyperlocal heating that disrupts cancer cell membranes while sparing surrounding tissue. The system is designed to remain inert outside activation windows and incorporates clearance pathways to minimize long‑term retention. This unified conceptual model demonstrates how geometry matching, dual‑key targeting, threshold‑based activation, and imaging‑guided control can be integrated into a single therapeutic platform. The framework provides a foundation for future experimental development and offers a coherent architecture for nanoscale precision treatment of HER2‑positive breast cancer.